0001650664-24-000081.txt : 20240627 0001650664-24-000081.hdr.sgml : 20240627 20240627170258 ACCESSION NUMBER: 0001650664-24-000081 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240627 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 241080180 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 8-K 1 edit-20240627.htm 8-K edit-20240627
0001650664FALSE00016506642024-06-272024-06-27

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________________________________________________________
FORM 8-K
_________________________________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 27, 2024
_________________________________________________________________________________________
Editas Medicine, Inc.
(Exact Name of Registrant as Specified in its Charter)
_________________________________________________________________________________________
Delaware001-3768746-4097528
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
11 Hurley Street

Cambridge, 		Massachusetts02141
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: (617) 401-9000
(Former Name or Former Address, if Changed Since Last Report)
__________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.0001 par value per shareEDITThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 27, 2024, Akshay Vaishnaw informed the Board of Directors (the “Board”) of Editas Medicine, Inc. (the “Company”) of his resignation from the Board effective as of June 30, 2024. Dr. Vaishnaw’s resignation was not caused by any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EDITAS MEDICINE, INC.
Date: June 27, 2024By:/s/ Gilmore O’Neill
Gilmore O’Neill
President & Chief Executive Officer

 EX-101.SCH 2 edit-20240627.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 edit-20240627_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 4 edit-20240627_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
Jun. 27, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 27, 2024
Entity File Number 001-37687
Entity Registrant Name Editas Medicine, Inc.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 46-4097528
Entity Address, Address Line One 11 Hurley Street
Entity Address, City or Town Cambridge,
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02141
City Area Code 617
Local Phone Number 401-9000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol EDIT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001650664
Amendment Flag false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Document and Entity Information Sheet http://www.editasmedicine.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports edit-20240627.htm edit-20240627.xsd edit-20240627_lab.xml edit-20240627_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "edit-20240627.htm": { "nsprefix": "edit", "nsuri": "http://www.editasmedicine.com/20240627", "dts": { "inline": { "local": [ "edit-20240627.htm" ] }, "schema": { "local": [ "edit-20240627.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "edit-20240627_lab.xml" ] }, "presentationLink": { "local": [ "edit-20240627_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.editasmedicine.com/role/DocumentandEntityInformation", "longName": "0000001 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "edit-20240627.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "edit-20240627.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.editasmedicine.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001650664-24-000081-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001650664-24-000081-xbrl.zip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end XML 16 edit-20240627_htm.xml IDEA: XBRL DOCUMENT 0001650664 2024-06-27 2024-06-27 0001650664 false 8-K 2024-06-27 Editas Medicine, Inc. DE 001-37687 46-4097528 11 Hurley Street Cambridge, MA 02141 617 401-9000 false false false false Common Stock, $0.0001 par value per share EDIT NASDAQ false